Overview
- Provides a contemporary perspective on the emerging links between COVID-19 and cardiovascular disease
- The first comprehensive approach on COVID-19 cardiac complications
- Offers clear recommendations on how to manage and avoid the increased number of COVID-19 related deaths
Part of the book series: Contemporary Cardiology (CONCARD)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (25 chapters)
-
Front Matter
-
General Part
-
Front Matter
-
-
Cardiovascular Complications of the Acute Phase of COVID-19
-
Front Matter
-
-
Influence of the Treatment of Cardiovascular Diseases on the Course of COVID-19
-
Front Matter
-
Keywords
- COVID-19 and Cardiology
- Cardiac Complications of COVID-19
- Cardiovascular System in COVID-19
- Long COVID-19
- Cardiology and Long-COVID-19
- Cardiovascular complications of Long-COVID
- Cardiomyopathy in COVID-19
- Stroke in COVID-19
- Pulmonary embolism after COVID-19
- Cardiac complications of drugs used in COVID-19 therapy
- The impact of the Covid-19 pandemic on the CVD diagnosis
- The impact of the COVID-19 pandemic on e-services
About this book
Chapters provide the reader with a contemporary perspective on the emerging links between COVID-19 and cardiovascular disease. In addition, this volume discusses the clinical implications and therapeutic goals in patients with COVID-19 and cardiac complications, as well as possible therapeutic options. It also offers clear recommendations on how to manage (both non- and pharmacologically) to avoid the increased number of COVID-19 related deaths due to CVD and its risk factors.
Cardiovascular Complications of COVID-19 will be the primary resource for physicians, residents, fellows, and nursed and medical students in the fields of cardiology and COVID-19/infectious diseases as well as healthcare providers that initiate preventive activities and dedicated programs.
Editors and Affiliations
About the editor
Prof. Maciej Banach was an Undersecretary of State at the Ministry of Science and Higher Education of the Republic of Poland (2010-2012), and a President of the Polish Mother's Memorial Hospital - Research Institute (PMMHRI) (2014-2021). He is a Head of Cardiovascular Research Centre at University of Zielona Gora, full Professor of Cardiology at the Medical University of Lodz (MUL) and PMMHRI, Head of Department of Preventive Cardiology and Lipidology at the Medical University of Lodz (MUL), Poland.
He is a Secretary of the European Atherosclerosis Society (EAS) (2021-2024) and member of the Scientific and Health Policy Advisory Group of the FH Europe. He is a Founder and Head of the Polish Lipid Association (PoLA) (2011-) and Lodz Chapter of Polish Society of Hypertension (2009-). He is the founder of the Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group (2012-) – a group of over 150 worldwide experts aimed to investigatethe most important issues in the field of lipid disorders, hypertension, nutrition and cardiovascular risk, as well as the President of the International Lipid Expert Panel (ILEP; ilep.eu) (2015-), currently with >100 recognized worldwide experts, which has been founded to prepare recommendations in the area of preventive cardiology, atherosclerosis and natural products in the most debatable issues that have not been covered in the existing guidelines. He is also a member of the REPROGRAM and CAPISCO Consortia – a group of experts challenging with Covid-19 pandemic, member of 2 largest worldwide databases – the Global Burden of Disease (GDB) (IHME, University of Washington, Seattle, US) and Non-Communicable Diseases Risk Factor Collaboration (NCD-RisC, Imperial College of London, UK). He is also Founder and President of the foundation – Think-Tank “Innovation for Health”, which gathers six main health research institutes and over 40 medical business representatives in Poland with main aim to make innovations in the medical area in Poland. He is a Visiting Professor of University of Alabama at Birmingham (UAB), University of Medicine and Pharmacy Victor Babes in Timisoara, Romania (2014-), and University of California, Irvine (UCI), CA, USA (2021-).
Prof. Banach has published over 1200 original articles, reviews, editorials, and book chapters in the field of hypertension, dyslipidemia, cardiology, and risk stratification. His combined IF (for only full-text manuscripts) is over 10,000 pts, number of citations: 45,364 (acc. Web of Science Core Collection/Publons), 51,348 (acc. SCOPUS), 61,108 (acc. ResearchGate), and 74,361 (acc. Google Scholar) with Hirsch’s Index = 80 (WoS/Publons), 81 (SCOPUS), 95 (ResearchGate) and 101 (i10-index: 634) (Google Scholar) – being within 1% the highest cited scientists in the world (in the research area of Clinical Medicine and Pharmacology and Toxicology) according to Essential Science Indicatorsby Clarivate (with 53 TOP Papers). Prof. Banach is also within top 5 worldwide experts according to ExpertScape in the field of statins (3), dyslipidemias (4), lipoproteins (4), HDL cholesterol (5) and LDL lipoproteins (5). He is also a 1% Top Reviewer in the areas of Clinical Medicine and Cross-Field (in 2018 and 2019) by Publons/Clarivate and Publons Academy Mentor.
Bibliographic Information
Book Title: Cardiovascular Complications of COVID-19
Book Subtitle: Acute and Long-Term Impacts
Editors: Maciej Banach
Series Title: Contemporary Cardiology
DOI: https://doi.org/10.1007/978-3-031-15478-2
Publisher: Humana Cham
eBook Packages: Medicine, Medicine (R0)
Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2022
Hardcover ISBN: 978-3-031-15477-5Published: 29 December 2022
Softcover ISBN: 978-3-031-15480-5Published: 30 December 2023
eBook ISBN: 978-3-031-15478-2Published: 28 December 2022
Series ISSN: 2196-8969
Series E-ISSN: 2196-8977
Edition Number: 1
Number of Pages: XV, 437
Number of Illustrations: 10 b/w illustrations, 49 illustrations in colour
Topics: Cardiology